Literature DB >> 6673896

Aeromonas species in clinical microbiology: significance, epidemiology, and speciation.

J M Janda, E J Bottone, M Reitano.   

Abstract

Over a one-year period, 32 strains (31 clinical, 1 environmental) of Aeromonas sp. were recovered. Chief sources of isolation were the gastrointestinal tract (48%), wounds (19%), and blood (13%). Gastrointestinal isolates were most often recovered from young (less than 5 yrs) children with diarrhea; wound or blood isolates were recovered more often from an older (avg. 56 yrs) population with one of several underlying disorders. Regardless of body site of isolation, most strains of Aeromonas appeared to be community acquired and not nosocomially transmitted. Over 70% of all isolates recovered during this year period were isolated during summer or fall months, suggesting a seasonal distribution of this microorganism. Speciation of Aeromonas isolates revealed A. hydrophila to be the predominant species isolated from clinical specimens, although significant percentages of other Aeromonas sp. were also recovered from clinical material.

Entities:  

Mesh:

Year:  1983        PMID: 6673896     DOI: 10.1016/0732-8893(83)90021-4

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  17 in total

1.  Aeromonas species in stabilization ponds in the arid region of Marrakesh, Morocco, and relation to fecal-pollution and climatic factors.

Authors:  A Boussaid; B Baleux; L Hassani; J Lesne
Journal:  Microb Ecol       Date:  1991-12       Impact factor: 4.552

2.  Enteric pathogens in tropical aquaria.

Authors:  D Sanyal; S H Burge; P G Hutchings
Journal:  Epidemiol Infect       Date:  1987-12       Impact factor: 2.451

3.  Cephalothin susceptibility as a potential marker for the Aeromonas sobria group.

Authors:  J M Janda; M R Motyl
Journal:  J Clin Microbiol       Date:  1985-11       Impact factor: 5.948

4.  beta-Lactam resistance of motile Aeromonas isolates from clinical and environmental sources.

Authors:  K Morita; N Watanabe; S Kurata; M Kanamori
Journal:  Antimicrob Agents Chemother       Date:  1994-02       Impact factor: 5.191

5.  Diarrhea and intestinal invasiveness of Aeromonas strains in the removable intestinal tie rabbit model.

Authors:  G Pazzaglia; R B Sack; A L Bourgeois; J Froehlich; J Eckstein
Journal:  Infect Immun       Date:  1990-06       Impact factor: 3.441

Review 6.  Recovery of uncommon bacteria from blood: association with neoplastic disease.

Authors:  J L Beebe; E W Koneman
Journal:  Clin Microbiol Rev       Date:  1995-07       Impact factor: 26.132

7.  Isolation and characterization of motile Aeromonas from human, food and environmental specimens.

Authors:  Y Nishikawa; T Kishi
Journal:  Epidemiol Infect       Date:  1988-10       Impact factor: 2.451

8.  Virulence markers of mesophilic aeromonads: association of the autoagglutination phenomenon with mouse pathogenicity and the presence of a peripheral cell-associated layer.

Authors:  J M Janda; L S Oshiro; S L Abbott; P S Duffey
Journal:  Infect Immun       Date:  1987-12       Impact factor: 3.441

9.  Biotyping of Aeromonas isolates as a correlate to delineating a species-associated disease spectrum.

Authors:  J M Janda; M Reitano; E J Bottone
Journal:  J Clin Microbiol       Date:  1984-01       Impact factor: 5.948

Review 10.  Wound infection with aerogenic Aeromonas strains: a review of twenty-seven cases.

Authors:  R D Isaacs; S D Paviour; D E Bunker; S D Lang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-06       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.